Breast cancer adaptive resistance: HER2 and cancer stem cell repopulation in a heterogeneous tumor society.
about
Therapies targeting cancer stem cells: Current trends and future challengesInhibiting stemness and invasive properties of glioblastoma tumorsphere by combined treatment with temozolomide and a newly designed biguanide (HL156A).Profiling global kinome signatures of the radioresistant MCF-7/C6 breast cancer cells using MRM-based targeted proteomicsDownregulation of Ras association domain family member 6 (RASSF6) underlies the treatment resistance of highly metastatic nasopharyngeal carcinoma cells.All-trans retinoic acids induce differentiation and sensitize a radioresistant breast cancer cells to chemotherapy.Plumbagin Suppresses the Invasion of HER2-Overexpressing Breast Cancer Cells through Inhibition of IKKα-Mediated NF-κB Activation.STAT3-survivin signaling mediates a poor response to radiotherapy in HER2-positive breast cancers.Cancer stem cells as a potential therapeutic target in breast cancerTargeted therapies in breast cancer: New challenges to fight against resistance.Potential use of glioblastoma tumorsphere: clinical credentialing.Adaptive stress signaling in targeted cancer therapy resistance.Induction of interleukin-1β by mouse mammary tumor irradiation promotes triple negative breast cancer cells invasion and metastasis development.Chromatin remodeling modulates radiosensitivity of the daughter cells derived from cell population exposed to low- and high-LET irradiation.Circulating Her-2/neu extracellular domain in breast cancer patients-correlation with prognosis and clinicopathological parameters including steroid receptor, Her-2/neu receptor coexpression.Oncogenic transformation of normal breast epithelial cells co-cultured with cancer cells
P2860
Q26777880-9BB70060-59B6-40D0-ABCB-8A5BCBD9482FQ30353578-CD29ADD9-9992-41D5-9891-0FF5675D4B2AQ34855520-745F1C00-93C0-4A6B-BBCC-FEA83F9AB140Q35207555-50BB24D3-CD11-4947-9B75-8713FEDE6A49Q35977057-FC9B94A1-D9E8-44E9-B3C2-7BFD9B34E60DQ36160375-4536FF24-3A5B-4EF9-A220-89784073689AQ36916416-9A8FF92C-6369-4176-BEC6-5D57DDB9A752Q37043792-FD566A5B-E36C-47D2-B0F5-C86110D4AB92Q37743048-CBEF3D3A-718E-4666-978D-E2BB7A918D2DQ38335033-F5BE7D13-CE10-4871-A70A-AF7066F23DF1Q38363739-984910D1-E7FE-4A9B-BEA1-87FEA641D3AAQ38726934-A175A1E5-E750-457C-9136-52968B7EC74DQ41592921-5EE3C9DC-6945-4195-9E0A-95730A35A0A3Q53006794-3228B6BD-7E4A-4DD2-8ADA-7AAE7E7D7E45Q58721230-FCDC59CA-1BF7-4157-9A8A-EB096EB9631B
P2860
Breast cancer adaptive resistance: HER2 and cancer stem cell repopulation in a heterogeneous tumor society.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Breast cancer adaptive resista ...... a heterogeneous tumor society.
@en
Breast cancer adaptive resista ...... a heterogeneous tumor society.
@nl
type
label
Breast cancer adaptive resista ...... a heterogeneous tumor society.
@en
Breast cancer adaptive resista ...... a heterogeneous tumor society.
@nl
prefLabel
Breast cancer adaptive resista ...... a heterogeneous tumor society.
@en
Breast cancer adaptive resista ...... a heterogeneous tumor society.
@nl
P2093
P2860
P921
P1476
Breast cancer adaptive resista ...... a heterogeneous tumor society.
@en
P2093
Demet Candas
Guochun Jiang
Jian Jian Li
Nadire Duru
P2860
P2888
P356
10.1007/S00432-013-1494-1
P577
2013-08-30T00:00:00Z
2014-01-01T00:00:00Z